Scope boundary · 18

Small does not mean low risk

Examine hard-to-detect loss, migration, heating, toxicity, accumulation, unintended interaction and retrieval difficulty created by small scale.

Evidence statusResearch-frontier evidence framework · stage, material, control and retrieval validation requiredLast reviewed: 16 August 2026
18

FUURAA thesis

Risk changes with scale; it does not monotonically decrease.

Engineering map

Turn the title into engineering objects that can be observed, measured and reviewed.

Each layer states the boundary to establish and the evidence needed for the next decision.

01

Detect

Define the smallest relevant unit or mass that can be located and measured.

02

Interact

Assess surface-area effects, field response, transport and biological or ecological contact.

03

Resolve

Plan retrieval, neutralisation, monitoring and response when direct handling is impossible.

Verification questions

Write the questions first, then decide whether a demo, test, pilot or operating record can answer them.

Each question needs an object, conditions, denominator, threshold and accountable decision owner.

  1. 01

    Which hazard becomes harder to observe at this scale?

  2. 02

    Can one missing unit matter biologically or operationally?

  3. 03

    What unique material behaviour appears?

  4. 04

    How long and where must residual effects be monitored?

Evidence to preserve

Enable the next reader to reconstruct conditions, results, failures and the decision.

A conclusion alone loses reviewability; raw records, configuration and exclusions matter too.

  1. 01

    Evidence package 1

    Scale-specific hazard and exposure analysis

  2. 02

    Evidence package 2

    Detection-limit and residual-material study

  3. 03

    Evidence package 3

    Longitudinal monitoring and response plan

Scope boundary

State what this evidence still cannot be generalised to.

Sources and evidence status

Read standards scope, measurement evidence and application conclusions separately.

Source dates and review status remain visible; external sources open in a new tab.

01
U.S. Food and Drug Administration · Final guidance 2014-06 · verified 2026-08-16

Considering whether an FDA-regulated product involves nanotechnology

Explains that dimension-dependent properties may require particular, product-specific attention to safety, effectiveness, quality and regulatory status.

02
ETH Zurich · Published 2025-11-13 · verified 2026-08-16

Magnetically guided microrobots for targeted drug delivery

Integrates a soluble capsule, magnetic navigation, X-ray visibility, catheter release and drug delivery, with testing in vascular models and large animals.

03
NIST · Published 2024-06 · verified 2026-08-16

Research Opportunities for Advancing Measurement Science for Manufacturing Robotics

Identifies soft-robotics measurement needs across actuation, sensor integration, control, power, fabrication and materials, and calls for comparison with rigid and other alternatives.